We encountered a case of native valve endocarditis due to Corynebacterium CDC group I1 which was successfully controlled with antimicrobial agents alone. This organism and three other isolates of this group were susceptible to penicillin, vancomycin, and gentamicin. The combination of penicillin with subinhibitory concentrations of gentamicin resulted in a 1,000-fold decrease in CFU per milliliter at 24 h compared with penicillin alone. Augmentation of killing was noted also with vancomycin plus gentamicin but to a degree that did not meet strict criteria for bactericidal synergism. [3] ). The group I1 patient, the first described with bacteremia due to this organism, was unusual in that he had no previously apparent valvular damage. He expired despite intensive therapy with vancomycin, gentamicin, and penicillin to which the organism was susceptible as determined by Kirby-Bauer disc diffusion methods.
Diphtheroids are ubiquitous in nature and, in addition to being found on human skin, can be found in soil or fresh or salt water, as well as on plants. They occasionally are encountered as human pathogens (8) . In particular, several groups of corynebacteria, some of which have been identified to species level, have been found to cause endocarditis, mostly involving prosthetic or damaged native heart valves. There have been a number of reports identifying Corynebacterium jeikeium as a cause of prosthetic valve endocarditis (5, 10) . There also have been reports of endocarditis due to other CDC coryneform groups of bacteria which have not been identified to species level, including group G2 (involving a prosthetic valve [1] ) and group I1 (involving all four native valves [3] ). The group I1 patient, the first described with bacteremia due to this organism, was unusual in that he had no previously apparent valvular damage. He expired despite intensive therapy with vancomycin, gentamicin, and penicillin to which the organism was susceptible as determined by Kirby-Bauer disc diffusion methods.
We also have encountered a case of Corynebacterium CDC group I1 native valve endocarditis involving an apparently abnormal aortic valve which was successfully controlled with antibiotics alone. This report describes inhibitory and bactericidal activities of several antimicrobial agents against this isolate as well as against three additional isolates obtained from the Centers for Disease Control. Bactericidal activity was tested by time-kill methods, and potential synergism between penicillin or vancomycin and gentamicin was evaluated.
A 53-year-old male, who was a long-standing resident of a mental health facility and had a history of an aortic insufficiency murmur, was admitted for evaluation of a febrile illness. He was well until 1 month prior to admission, when he was given a 10-day course of cephalexin (500 mg taken four times daily) for a left-foot cellulitis accompanied by a low-grade fever. He Because of a penicillin allergy, therapy with vancomycin and gentamicin was initiated. Progressive atrioventricular block developed within 48 h of admission, leading to complete heart block. This necessitated placement of a permanent pacemaker but the patient was not felt to be a candidate for further surgical intervention. However, following 2 weeks of combined antimicrobial therapy, he became afebrile and returned to a normal sinus rhythm with a normal P-R interval. He completed an additional 4 weeks of parenteral therapy with vancomycin alone. Because a cardiac abscess was suspected but evidence for microbiologic cure could not be obtained, he was discharged on oral erythromycin for continued suppression. All follow-up blood cultures remained negative, and the patient remained free of recurrent disease 7 months following discharge.
The patient's strain was identified as Corynebacterium CDC group I1 by the Massachusetts Department of Public Health State Laboratory Institute. Three additional strains, E-8873, F-435, and F-8257, were kindly provided by Robert E. Weaver of the Centers for Disease Control in Atlanta, Ga. These strains had been isolated from orbital fat, uterus, and wound cultures, respectively.
All four strains grew readily in brain heart infusion (Difco Laboratories, Detroit, Mich.) broth to a concentration of greater than 108 CFU/ml at 24 h of incubation. Smooth, white alpha-hemolytic colonies approximately 0.5 to 1.0 mm in diameter were clearly visible within 24 h of incubation at 35°C on horse blood agar plates (brucella agar with 5% horse blood). MICs against all four strains were determined by a macrodilution method in brain heart infusion broth with an inoculum of 5 x 105 CFU/ml. Table 1 . The susceptibilities of the four strains to each of the antimicrobial agents were quite uniform. The MBC of vancomycin, however, varied from 4 ,ug/ml for our isolate to 64 ,g/ml for one of the other three strains. Penicillin, clindamycin, chloramphenicol, ceftriaxone, and tetracycline all were bacteriostatic at clinically achievable concentrations, with ceftriaxone significantly less active than penicillin. Both gentamicin and ciprofloxacin were bactericidal at concentrations near the MIC. Erythromycin also exerted bactericidal activity but to a lesser degree. Rifampin initially appeared to be bactericidal at very low concentrations. However, at an inoculum of 5 x 105 CFU/ml, a "skip-tube" phenomenon frequently was noted during repeated MIC testing. This suggested a high rate of mutation to resistance, making interpretation of results unpredictable and unreliable.
Results of synergism studies for our isolate are displayed in Fig. 1 and 2 . The bacteriostatic nature of penicillin is well represented in Fig. 1 , in which only a minor decrease in CFU per milliliter is observed following 24 h of incubation with 10 pLg of this agent per ml. Most striking was the extreme susceptibility of each strain to very low concentrations of gentamicin. At a concentration of 3 ,ug/ml, no colonies were detected following 4 h of incubation (data not shown). A concentration of 0.03 ,ug/ml was needed for evaluation of synergy because any concentration above this had a measurable effect on growth. When penicillin was combined with this dose of gentamicin, a 1,000-fold decrease in CFU per milliliter was noted at 24 h relative to the initial inoculum and to final colony counts observed with penicillin alone. Vancomycin appeared significantly bactericidal at a dose of 10 ,ug/ml (Fig. 2) , and combination with gentamicin resulted in a 30-fold augmentation of killing, but this did not meet strict criteria for synergism. Similar results of synergism were obtained with CDC isolate F-8257, for which the MBCs of penicillin and vancomycin were greater than 128 and equal to 64 ,ug/ml, respectively. Combination of vancomycin with subinhibitory concentrations of gentamicin resulted in a 50-fold decrease in CFU per milliliter at 24 h relative to the initial inoculum and to final colony counts observed with vancomycin alone. Though again this did not meet strict criteria for bacterial synergism, an overall 1,000-fold decrease in CFU per milliliter was noted at 24 h relative to the initial inoculum.
Diphtheroids now are a well-known cause of endocarditis, primarily involving prosthetic or damaged heart valves (2, 4, 6, 7, 9, 12) . C. jeikeium appears to be the most common of these organisms implicated in endocarditis. In a review of 184 patients, diphtheroids accounted for 9% of early-onset and 4% of late-onset prosthetic valve endocarditis cases (13 There have been a number of reports of endocarditis with organisms other than C. jeikeium, including one previous report of native valve endocarditis with Corynebacterium CDC group Il (3). The present study provides detailed susceptibility data for this group. Though the CDC group I1 isolates appear quite susceptible to penicillin by MIC testing, they are resistant to killing by this agent. These data, along with the knowledge that C. jeikeium can be resistant to penicillin, support initial combination therapy with gentamicin pending further identification and susceptibility testing. Also, vancomycin appears to be uniformly active against all groups studied thus far, including group I1, and might be considered for initial therapy, but it may not be bactericidal against some isolates, as we have shown. Vancomycin and gentamicin might be used in combination for a brief period, not so much for potential synergism as for the benefits of the highly bactericidal activity of gentamicin at low concentrations.
